Vaccine PvCS N+C+R 150 mcg
MVDC-2021-001
Phase 2 mab active
Quick answer
Vaccine PvCS N+C+R 150 mcg for Malaria, Vivax is a Phase 2 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Malaria, Vivax
- Phase
- Phase 2
- Modality
- mab
- Status
- active